Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. SIX1 aggravates the progression of spinal cord injury in mice by promoting M1 polarization of microglia

SIX1 aggravates the progression of spinal cord injury in mice by promoting M1 polarization of microglia

Scientific Reports, 2025 · DOI: https://doi.org/10.1038/s41598-024-82121-3 · Published: January 8, 2025

Spinal Cord InjuryImmunologyGenetics

Simple Explanation

Spinal cord injury (SCI) can cause permanent loss of motion or sensation. After the initial physical damage, the body responds with inflammation, which paradoxically can worsen the injury. This study focuses on how a protein called SIX1 affects inflammation after SCI in mice. Microglia, which are immune cells in the spinal cord, can either promote (M1) or reduce (M2) inflammation. The researchers found that SIX1 increases after SCI and seems to push microglia towards the M1 type, worsening inflammation. By blocking SIX1, the researchers were able to shift microglia towards the M2 type, reduce inflammation, and improve recovery in mice with SCI. This suggests that targeting SIX1 could be a new way to treat SCI.

Study Duration
35 days
Participants
Male C57BL/6J mice aged at 6–8 weeks
Evidence Level
Not specified

Key Findings

  • 1
    SIX1 expression increases in microglia following SCI in mice and is positively correlated with the M1 microglia marker iNOS and negatively correlated with the M2 microglia marker Arg1.
  • 2
    Knockdown of SIX1 promotes locomotor function recovery by enhancing M2 microglia polarization in mice with SCI.
  • 3
    SIX1 enhances the transcription of VEGF-C in LPS-stimulated BV2 cells by downregulating EZH2, and VEGF-C promotes M1 polarization and inhibits M2 polarization by binding to VEGFR3.

Research Summary

This study investigates the role of SIX1 in microglia polarization following spinal cord injury (SCI) in mice. The researchers found that SIX1 expression increases in microglia after SCI and promotes M1 polarization, exacerbating inflammation and hindering recovery. The study reveals that SIX1 promotes M1 polarization by upregulating the VEGF-C/VEGFR3 axis in microglia. Downregulation of EZH2 promotes SIX1 expression in LPS-treated BV2 cells by inhibiting the methylation of the SIX1 promoter. Knockdown of SIX1 was shown to enhance M2 microglia polarization and promote locomotor function recovery in mice with SCI, suggesting SIX1 as a potential therapeutic target for SCI.

Practical Implications

Therapeutic Target

SIX1 may represent a novel therapeutic target for treating spinal cord injury by modulating microglia polarization.

Drug Development

SIX1 inhibitors could be developed as potential drugs to improve recovery following SCI.

VEGF-C/VEGFR3 Axis Modulation

Targeting the VEGF-C/VEGFR3 axis downstream of SIX1 could also be a strategy to reduce inflammation and promote recovery in SCI.

Study Limitations

  • 1
    The concentration and treatment duration of LPS was not optimized
  • 2
    Electrophysiological analysis of the mouse spinal cord to record motoneuron discharges was not performed.
  • 3
    The mouse primary microglia were not used to further validate our results.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury